PROSTACIDIN Trademark

Trademark Overview

On Thursday, August 19, 2010, a trademark application was filed for PROSTACIDIN with the United States Patent and Trademark Office. The USPTO has given the PROSTACIDIN trademark a serial number of 85110951. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 17, 2014. This trademark is owned by Bioniche Life Sciences Inc.. The PROSTACIDIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment of cancer of the prostate; biological preparations for the treatment of cancer of the prostate
prostacidin

General Information

Serial Number85110951
Word MarkPROSTACIDIN
Filing DateThursday, August 19, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 17, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and Servicespharmaceuticals for the treatment of cancer of the prostate; biological preparations for the treatment of cancer of the prostate

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioniche Life Sciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N1E2
CA
Party NameBioniche Life Sciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N1E2
CA

Trademark Events

Event DateEvent Description
Monday, March 17, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 17, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2013EXTENSION 5 GRANTED
Wednesday, July 31, 2013EXTENSION 5 FILED
Wednesday, July 31, 2013TEAS EXTENSION RECEIVED
Thursday, February 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 13, 2013EXTENSION 4 GRANTED
Tuesday, February 5, 2013EXTENSION 4 FILED
Tuesday, February 5, 2013TEAS EXTENSION RECEIVED
Friday, July 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2012EXTENSION 3 GRANTED
Tuesday, July 17, 2012EXTENSION 3 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Thursday, February 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2012EXTENSION 2 GRANTED
Thursday, January 26, 2012EXTENSION 2 FILED
Wednesday, February 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 26, 2012TEAS EXTENSION RECEIVED
Friday, July 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2011EXTENSION 1 GRANTED
Wednesday, July 20, 2011EXTENSION 1 FILED
Wednesday, July 20, 2011TEAS EXTENSION RECEIVED
Tuesday, February 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 9, 2010ASSIGNED TO LIE
Wednesday, October 27, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 27, 2010ASSIGNED TO EXAMINER
Tuesday, August 24, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 23, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

prostacidin prostate cancer treatment preparations biological pharmaceuticals